Access1 Access2 Access3 Medication & Drugs Skin May 5, 2022 HSA Approves New JAK inhibitor Abrocitinib (Cibinqo) For The Treatment of Atopic Dermatitis
Access1 Access2 Access3 Medication & Drugs Muscles & Joints March 17, 2022 Upadacitinib (Rinvoq): Once-Daily Oral Treatment for Rheumatoid Arthritis (RA)